Workflow
BOW(300070)
icon
Search documents
碧水源:公司技术以膜技术为主
Zheng Quan Ri Bao· 2025-11-17 11:07
Group 1 - The company, BWSY, emphasized that its technology primarily focuses on membrane technology in response to investor inquiries on November 17 [2]
碧水源:未参与中交集团在滇池上投入使用的“藻水共治”一体化平台项目
Mei Ri Jing Ji Xin Wen· 2025-11-17 00:55
Core Viewpoint - The company BWS (碧水源) confirmed that it did not participate in the "algae-water co-governance" integrated platform project utilized by China Communications Construction Group (中交集团) at Dianchi Lake [2] Company Summary - BWS clarified its non-involvement in the project when questioned by investors on the interactive platform [2]
碧水源:目前尚无质子交换膜产品
Mei Ri Jing Ji Xin Wen· 2025-11-17 00:47
Group 1 - The company, BWS (碧水源), currently does not have any proton exchange membrane products [1] - There are no plans for large-scale production of proton exchange membrane products at this time [1]
碧水源:11月14日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-11-14 08:36
Company Overview - BWS (碧水源) announced on November 14 that its 18th meeting of the 6th Board of Directors was held, discussing the proposal to convene the second extraordinary shareholders' meeting of 2025 [1] - As of the report, BWS has a market capitalization of 16.2 billion yuan [1] Financial Performance - For the first half of 2025, BWS's revenue composition is as follows: Environmental protection and water treatment account for 87.71%, while the municipal sector accounts for 12.29% [1]
碧水源(300070) - 关于召开2025年第二次临时股东会的通知
2025-11-14 08:30
证券代码:300070 证券简称:碧水源 公告编号:2025-067 北京碧水源科技股份有限公司 关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 北京碧水源科技股份有限公司(以下简称"公司")第六届董事会第十八次 会议决定于 2025 年 12 月 1 日(星期一)召开 2025 年第二次临时股东会,会议 有关事项如下: 一、召开会议基本情况 1. 股东会届次:2025 年第二次临时股东会 2. 股东会的召集人:董事会。 3. 本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所 创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号—创业板 上市公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》 的有关规定。 8. 会议地点:北京市海淀区生命科学园路 23-2 号碧水源大厦会议室 4. 会议时间: (1)现场会议时间:2025 年 12 月 1 日(星期一)09:30 (2)网络投票时间:通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 12 月 1 日 9:1 ...
碧水源(300070) - 第六届董事会第十八次会议决议公告
2025-11-14 08:30
证券代码:300070 证券简称:碧水源 公告编号:2025-066 北京碧水源科技股份有限公司 第六届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 公司于 2018 年 6 月 11 日召开的第四届董事会第七次会议、2018 年 7 月 9 日召开的 2018 年第三次临时股东大会审议通过了《关于为中宁县碧水源水务有 1 限公司提供担保的议案》,同意公司为中宁县碧水源水务有限公司向中信银行 股份有限公司银川分行申请的金额不超过人民币 66,900 万元的项目贷款提供全 额连带责任保证担保,担保期限自协议生效之日起 20 年。具体担保内容详见公 司于 2018 年 6 月 11 日在中国证监会指定创业板信息披露媒体上的公告(公告 编号:2018-070)。由于该项目贷款已提前结清,公司本次提前终止该担保事 项。 本议案以 8 票同意,0 票反对,0 票弃权获得通过。本议案尚需提交公司股 东会审议。 北京碧水源科技股份有限公司(以下简称"公司")第六届董事会第十八 次会议于 2025 年 11 月 14 日上午 9:30 在公司会议 ...
碧水源(300070) - 2025年11月11日投资者关系活动记录表
2025-11-12 10:38
Group 1: Company Strategy and Development - The company is focusing on a strategic transformation to enhance operational quality and efficiency through business structure adjustments [2][3] - The core strategy, termed "12256 Strategy," aims to optimize business layout and expand market share in core areas such as membrane products and water operations [2] - The company is transitioning from a model of large investments and projects to one emphasizing high value-added businesses, targeting quality and efficiency improvements [2][3] Group 2: New Business Directions - The company is prioritizing three high-potential new business areas aligned with national strategic emerging industries: high-end membrane materials, resource utilization, and applications in the biopharmaceutical sector [3] - In high-end membrane materials, the focus is on pharmaceutical and industrial specialty membranes, with a current domestic market reliance on imports below 30%, indicating significant potential for domestic substitution [3] - The company is also expanding into salt lake resource utilization and seawater desalination, supported by favorable policies and growing market demand [3] Group 3: Operational Challenges and Solutions - The company is addressing significant accounts receivable pressures, a legacy issue from previous expansive growth, through targeted recovery strategies [4] - A special task force has been established to enhance collection efforts, particularly for long-aged receivables, and the company is actively participating in local government debt resolution initiatives [4] - Recent financing announcements are part of normal operations to manage cash flow and are not indicative of any immediate operational risks [4]
碧水源11月11日获融资买入3252.26万元,融资余额7.93亿元
Xin Lang Cai Jing· 2025-11-12 01:29
Group 1 - The core viewpoint of the news is that BWS (Beijing Enterprises Water Group) has experienced fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks in the environmental sector [1][2]. Group 2 - As of November 11, BWS's stock price increased by 0.45%, with a trading volume of 166 million yuan. The margin trading data shows a net buying of 9.39 million yuan on that day, with a total margin balance of 802 million yuan [1]. - The financing balance of BWS is 793 million yuan, accounting for 4.88% of its market capitalization, which is below the 20th percentile level over the past year, indicating a low financing level [1]. - In terms of securities lending, BWS repaid 39,000 shares and sold 4,000 shares on November 11, with a remaining short position of 1.886 million shares, which is above the 90th percentile level over the past year, indicating a high level of short selling [1]. - For the period from January to September 2025, BWS reported a revenue of 4.372 billion yuan, a year-on-year decrease of 7.96%, and a net profit attributable to shareholders of -796.36 million yuan, a decline of 85.44% year-on-year [2]. - BWS has distributed a total of 1.777 billion yuan in dividends since its A-share listing, with 279 million yuan distributed in the last three years [2]. - As of October 31, the number of BWS shareholders was 74,400, a decrease of 0.13%, while the average circulating shares per person increased by 0.13% to 45,336 shares [2].
碧水源:目前通过内部外部相结合的方式解决应收账款问题
Zheng Quan Ri Bao· 2025-11-10 08:37
Core Viewpoint - The company, BWS, has experienced a slight increase in accounts receivable due to new orders, which is considered a normal part of its operations [2] Group 1: Accounts Receivable Management - The company is addressing accounts receivable issues through a combination of internal and external strategies [2] - There is a strong emphasis on the collection of accounts receivable and other receivables, with measures including assessments and rewards/punishments implemented [2] - A dedicated team has been established to focus on the collection of long-aged accounts receivable [2] Group 2: Debt Management Initiatives - The company is actively participating in local government debt resolution plans, with some projects having been successfully implemented in the past two years [2] - The company is working to secure further debt resolution plans in the upcoming stages [2]
碧水源:应收账款2025年半年度按组合计提坏账准备变动金额为3.39亿元
Zheng Quan Ri Bao Wang· 2025-11-10 08:12
Core Insights - The company disclosed that the provision for bad debts related to accounts receivable for the first half of 2025 is expected to be 339 million yuan, with recoveries or reversals amounting to 161 million yuan [1] Group 1 - The company responded to investor inquiries regarding accounts receivable on November 10 [1] - The company emphasized the importance of monitoring its periodic reports for detailed information on accounts receivable [1]